DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
van Hazel GA, Heinemann V, Sharma NK et al.
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer.
J Clin Oncol 2016;
34: 1723-1731
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.